![Robert Newman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Robert Newman is Chief Operating Officer at TissueGene, Inc. Mr. Newman was previously employed as Senior VP-Clinical Operations & Manufacturing by ZIOPHARM Oncology, Inc., Vice President-Business Operations by ZIOPHARM Oncology, Inc., and Chief Operating Officer by Chymic Therapeutics, Inc.
Ehemalige bekannte Positionen von Robert Newman
| Unternehmen | Position | Ende |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Geschäftsführer | - |
| KOLON TISSUEGENE, INC. | Geschäftsführer | - |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Chymic Therapeutics, Inc.
 Chymic Therapeutics, Inc. Medical SpecialtiesHealth Technology Provides medical therapeutic services | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Kolon TissueGene, Inc.
 Kolon TissueGene, Inc. Medical SpecialtiesHealth Technology Provides orthopedic therapeutic products | Health Technology |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Chymic Therapeutics, Inc.
Chymic Therapeutics, Inc. Medical SpecialtiesHealth Technology Provides medical therapeutic services | Health Technology |
Wählen Sie MarketScreener 
